A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis

Icahn School of Medicine at Mount Sinai, New York

Thomas Jefferson University, Philadelphia

University of Pennsylvania, Department of Neurology, Philadelphia

Georgetown University Hospial, Research Pharmacy Servcies, Washington D.C.

The Emory Clinic, Atlanta

Neurology Associates of Ormond Beach, Ormond Beach

Compass Research, Orlando

University of Miami, Dept. of Neurology, Miami

UHealth at Boca Raton, Boca Raton

JEM Research Institute, Atlantis

Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton

University of Florida Parkinson's Disease and Movement Disorder's Center, Tampa

Suncoast Neuroscience Associates, Inc., St. Petersburg

Parkinson's Disease Treatment Center of Southwest Florida, Port Charlotte

Brian Maddux, Cincinnati

Henry Ford West Bloomfield Hospital, West Bloomfield

Rush University Medical Center, Chicago

Washington University School of Medicine, St Louis

University of Kansas Medical Center, Kansas City

The Movement Disorder Clinic of Oklahoma, Tulsa

Keck School of Medicine of USC/ University of Southern California, Los Angeles

CiTrials, Riverside

Neuuro-Pain Medical Center, Fresno

Inland Northwest Research, Spokane